| GTO ID | GTC0709 |
| Trial ID | ACTRN12613000198729 |
| Disease | Metastatic Melanoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Generation | 3rd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Study of increasing doses of genetically modified GD2-specific T cells in patients with metastatic melanoma and refractory solid tumours |
| Year | 2013 |
| Country | Australia |
| Company sponsor | Royal Adelaide Hospital Cancer Centre |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||